Conditions: Asthma; Moderate AsthmaInterventions: Drug: REGN3500; Drug: PlaceboSponsors: Regeneron Pharmaceuticals; SanofiNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
Condition: AsthmaInterventions: Drug: Fluticasone furoate (FF) Dry Powder Inhaler; Drug: Fluticasone propionate (FP) Dry Powder Inhaler; Drug: Budesonide (BUD) Turbuhaler; Drug: Placebo (ELLIPTA or DISKUS)Sponsor: GlaxoSmithKlineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study
A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma
Asthma L-Citrulline Pilot Study
An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
Condition: Bronchial AsthmaInterventions: Drug: Ke Chuan Liu Wei Mixture; Drug: Chuan Xiong Ping Chuan Mixture; Drug: Xie Wu Capsule; Drug: Dan Ma Jia Tablet; Drug: Zhi Chuan Capsule; Drug: Bu Shen Na Qi Granule; Drug: Ke Chuan Liu Wei Mixture placebo; Drug: Chuan Xiong Ping Chuan Mixture placebo; Drug: Xie Wu Capsule placebo; Drug: Dan Ma Jia Tablet placebo; Drug: Zhi Chuan Capsule placebo; Drug: Bu Shen Na Qi Granule placeboSponsor: Shanghai University of Traditional Chinese MedicineNot yet recruiting – verified October 2016…
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594Sponsor: AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days